Notably, CD36 overexpression in breast and gastric cancers has been demonstrated to mediate metabolic rewiring to favor FAO [17,40], as well as confer metabolic plasticity during nutrient deprivation [52]. The gene discussed is CD36; the disease is gastric cancer.